Lipocine (NASDAQ:LPCN) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of Lipocine stock opened at $4.01 on Thursday. Lipocine has a fifty-two week low of $2.31 and a […]

Related Keywords

,Millennium Management ,Topco Ltd ,Renaissance Technologies ,Goldman Sachs Group Inc ,Lipocine Inc ,Free Report ,Sachs Group ,State Street Corp ,Street Corp ,Get Free Report ,Lipocine Daily ,Lipocine ,Nasdaq Lpcn ,Lpcn ,Medical ,Initiated Coverage ,Stocknews Com ,